These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30035417)

  • 1. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
    Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
    Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain-derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity.
    Philippova ES; Bazhenov IV; Ziryanov AV; Bazarny VV
    Neurourol Urodyn; 2021 Jan; 40(1):95-101. PubMed ID: 33034916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary biomarkers profiles in patients with neurogenic detrusor overactivity according to their neurological condition.
    Richard C; Bendavid C; Hascoet J; Alimi Q; Khene ZE; Kerdraon J; Voiry C; Brochard C; Bouguen G; Siproudhis L; Manunta A; Gamé X; Peyronnet B
    World J Urol; 2020 Sep; 38(9):2261-2268. PubMed ID: 31741027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Michaluk-Skutnik J; Wasilewska A; Płoński G
    Scand J Urol; 2013 Oct; 47(5):411-7. PubMed ID: 23301927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary biomarkers in patients with detrusor underactivity with and without bladder function recovery.
    Chen SF; Jiang YH; Kuo HC
    Int Urol Nephrol; 2017 Oct; 49(10):1763-1770. PubMed ID: 28770419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia.
    Sekerci CA; Tanidir Y; Toprak T; Basok BI; Isman F; Simsek F; Akbal C; Tarcan T
    J Urol; 2019 Jan; 201(1):174-180. PubMed ID: 30577408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve Growth Factor and Brain-Derived Neurotrophic Factor as Potential Biomarkers of Mirabegron Efficacy in Patients with Overactive Bladder Syndrome.
    Beta A; Giannouli A; Rizos D; Mantzou A; Deligeoroglou E; Bakas P
    Int Urogynecol J; 2024 Jun; 35(6):1317-1322. PubMed ID: 38761233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor does not seem to be a biomarker for neurogenic lower urinary tract dysfunction after spinal cord injury.
    Krebs J; Pavlicek D; Stoyanov J; Pannek J; Wöllner J
    Neurourol Urodyn; 2017 Mar; 36(3):659-662. PubMed ID: 26950046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia.
    Top T; Sekerci CA; Isbilen-Basok B; Tanidir Y; Tinay I; Isman FK; Akbal C; Simsek F; Tarcan T
    Neurourol Urodyn; 2017 Sep; 36(7):1896-1902. PubMed ID: 28090659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
    Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
    BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
    Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
    Urologiia; 2015; (3):19-22. PubMed ID: 26390554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.
    Wang LW; Han XM; Chen CH; Ma Y; Hai B
    Int Urol Nephrol; 2014 Feb; 46(2):341-7. PubMed ID: 23982767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The profile of urinary biomarkers in overactive bladder.
    Rada MP; Ciortea R; Măluţan AM; Doumouchtsis SK; Bucuri CE; Clim A; Roman A; Mihu D
    Neurourol Urodyn; 2020 Nov; 39(8):2305-2313. PubMed ID: 32813897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT; Chancellor MB; Kuo HC
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013.
    Fry CH; Sahai A; Vahabi B; Kanai AJ; Birder LA
    Neurourol Urodyn; 2014 Jun; 33(5):602-5. PubMed ID: 24436105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary TIMP-2 and MMP-2 are significantly associated with poor bladder compliance in adult patients with spina bifida.
    Peyronnet B; Richard C; Bendavid C; Naudet F; Hascoet J; Brochard C; Senal N; Jezequel M; Alimi Q; Khene ZE; Corlu A; Clément B; Siproudhis L; Bouguen G; Kerdraon J; Manunta A; Gamé X
    Neurourol Urodyn; 2019 Nov; 38(8):2151-2158. PubMed ID: 31486131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overactive bladder: urodynamic characteristics of detrusor overactivity due to the etiology of low urinary tract dysfun- ction].
    Philippova ES; Bazhenov IV; Ziryanov AV; Zhuravlev VN
    Urologiia; 2021 Jun; (3):39-44. PubMed ID: 34251099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
    Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P
    PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
    Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
    J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.